Sponsor / FDA Meetings 

B&H has coordinated and participated in more than 125 formal face-to-face and teleconference meetings, as well as informal teleconferences with FDA. The types of meetings are as follows:

• Type A:                                      5%
• Type B:
  • Pre‑IND:                          20%
  • End‑of‑Phase 2:              20%
  • Pre‑NDA:                        20%
  • Type C Guidance:            25%
  • Informal Teleconference:   10%